Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.7186
-0.0274 (-3.67%)
Mar 31, 2025, 2:32 PM EDT - Market open
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $37.20 million as of March 31, 2025. Its market cap has increased by 93.07% in one year.
Market Cap
37.20M
Enterprise Value
-10.39M
1-Year Change
93.07%
Ranking
Category
Stock Price
$0.72
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $37.20M, a decrease of -91.28%. That is a compound annual growth rate of -50.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 38.62M | -11.54% |
| Dec 31, 2024 | 43.66M | 188.36% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |